1、 2025 Biomedtracker Datamonitor Healthcare Post-ASCO Report June 2025 Brought to you by:Summary The 2025 Annual Meeting of the American Society of Clinical Oncology(ASCO)was held in Chicago from May 30th-June 3rd,2025.This post-meeting report features commentary from our analysts on key presentation

2、s at the conference as well as a compilation of all data events added to Biomedtracker in conjunction with the meeting.As a reminder,our ASCO coverage will continue throughout the conference and beyond.Our coverage will include:June 16 Post-ASCO Webinar June 20 Post-ASCO Podcast About the Author Bio

3、medtracker is an independent research service that offers proprietary clinical assessments and patient-based revenue forecasts of developmental drugs within a comprehensive and intuitive drug information database.Clients from the pharmaceutical,biotech,and investment industries rely on Biomedtracker

4、 for its insight on the likelihood of approval,commercial potential,and future data and regulatory catalysts for drugs within the competitive landscape of every important disease and indication.Over the last several years,Biomedtracker has become the leader in providing objective information alongsi

5、de evidence based clinical assessments and investment research on pipeline drugs worldwide.For more information on getting direct access to Biomedtracker,please email .Disclaimer Copyright 2025 Evaluate,a Norstella company This report is published by Evaluate(the Publisher).This report contains info

6、rmation from reputable sources and although reasonable efforts have been made to publish accurate information,you assume sole responsibility for the selection,suitability and use of this report and acknowledge that the Publisher makes no warranties(either express or implied)as to,nor accepts liabili